Concomitant Sub-ablative Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition in Recurrent and Metastatic Head and Neck Cancer
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S225
DOI: 10.1016/j.ijrobp.2026.06.478 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von M.T. Yilmaz und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yilmaz, M., Aksoy, S., Cengiz, M., Guven, D., Guneyli, A., Ozyigit, G., Gullu, I., Sari, S., & Yazici, G. (2026). Concomitant Sub-ablative Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition in Recurrent and Metastatic Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics, 126(1), S225. https://doi.org/10.1016/j.ijrobp.2026.06.478
Vancouver
Yilmaz M, Aksoy S, Cengiz M, Guven D, Guneyli A, Ozyigit G, et al. Concomitant Sub-ablative Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition in Recurrent and Metastatic Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S225. doi:10.1016/j.ijrobp.2026.06.478
BibTeX
@article{Yilmaz2026,
author = {Yilmaz, M.T. and Aksoy, S. and Cengiz, M. and Guven, D.C. and Guneyli, A. and Ozyigit, G. and Gullu, I.H. and Sari, S.Yuce and Yazici, G.},
title = {Concomitant Sub-ablative Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition in Recurrent and Metastatic Head and Neck Cancer},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S225},
doi = {10.1016/j.ijrobp.2026.06.478}
}
EUVIMED